HHS, FDA Issue RFI on Deregulatory Plan to Lower Costs and Empower Providers
- the Department of Health and Human Services (HHS) and the Food and Drug Governance (FDA) have launched a public Request for Facts (RFI) to identify and eliminate outdated...
- HHS Secretary Robert F. Kennedy, Jr., committed the department to a "10-to-1" deregulatory policy.
- Kennedy said that to make America healthy again,doctors and caregivers must be freed to prevent and treat chronic disease,and their time should not be wasted on bureaucratic red...
HHS and the FDA are taking decisive action to slash red tape, seeking public input to identify and remove outdated regulations in a bid to lower costs and empower providers. This Request for Information (RFI) aligns with a government-wide push to reduce regulatory burdens and boost clarity, aiming to free up healthcare professionals and allow them to focus on patient care. HHS Secretary Robert F. Kennedy,Jr., has committed to a “10-to-1” deregulatory policy. The FDA wants to restore common sense to healthcare regulations.News Directory 3 keeps you informed. the 60-day public comment period is now open, offering stakeholders a chance to shape the future of healthcare regulations.Discover what’s next as HHS considers public proposals?
HHS, FDA Seek Public Input to Cut Outdated Regulations
the Department of Health and Human Services (HHS) and the Food and Drug Governance (FDA) have launched a public Request for Facts (RFI) to identify and eliminate outdated or needless regulations. This effort supports a broader federal initiative to reduce regulatory burdens and enhance transparency, aligning with Executive Order 14192.
HHS Secretary Robert F. Kennedy, Jr., committed the department to a “10-to-1” deregulatory policy. For every new regulation proposed, at least ten existing ones will be rescinded. The goal is to lower living costs, remove bureaucratic obstacles, and allow health care providers to focus on patient care.
Kennedy said that to make America healthy again,doctors and caregivers must be freed to prevent and treat chronic disease,and their time should not be wasted on bureaucratic red tape.
Under the executive order, HHS will implement a 10-to-1 rule, a regulatory cost cap, an expanded scope, and radical transparency.
FDA Commissioner Marty Makary said the initiative is about restoring common sense to health care regulation. By cutting outdated red tape, costs can be lowered, access to innovation increased, and clinicians can spend more time with patients.
The 60-day public comment period is now open. Stakeholders can submit ideas through the Regulations.gov docket (AHRQ-2025-0001) or the online portal at Regulations.gov/Deregulation.
What’s next
HHS will review public comments and consider proposals for deregulatory actions.